These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 2467816)

  • 1. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
    Moll H; Scollay R
    Eur J Immunol; 1989 Feb; 19(2):307-14. PubMed ID: 2467816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice.
    Milon G; Titus RG; Cerottini JC; Marchal G; Louis JA
    J Immunol; 1986 Feb; 136(4):1467-71. PubMed ID: 2418115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of variables associated with promotion of resistance and its abrogation in T cell-reconstituted nude mice infected with Leishmania major.
    Moll H; Mitchell GF
    J Parasitol; 1988 Dec; 74(6):993-8. PubMed ID: 3264023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell antigen receptor expression by subsets of Ly-2-L3T4- (CD8-CD4-) thymocytes.
    Wilson A; Ewing T; Owens T; Scollay R; Shortman K
    J Immunol; 1988 Mar; 140(5):1470-6. PubMed ID: 2450128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD; Locksley RM; Tubbs C; Raff HV
    J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to cutaneous leishmaniasis in nude mice injected with L3T4+ T cells but not with Ly-2+ T cells.
    Moll H; Scollay R; Mitchell GF
    Immunol Cell Biol; 1988 Feb; 66 ( Pt 1)():57-63. PubMed ID: 3259538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells.
    Bogdan C; Schröppel K; Lohoff M; Röllinghoff M; Solbach W
    Eur J Immunol; 1990 Dec; 20(12):2533-40. PubMed ID: 1980108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
    Solbach W; Forberg K; Kammerer E; Bogdan C; Röllinghoff M
    J Immunol; 1986 Jul; 137(2):702-7. PubMed ID: 3487578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
    Liew FY; Howard JG; Hale C
    J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attempts to assess the contribution of T lymphocytes from the L3T4+ and LYT2+ subsets in the immunological control of cutaneous leishmaniasis.
    Louis JA; Titus RG; Mendonca SC; Marchal G; Milon G
    Lepr Rev; 1986 Dec; 57 Suppl 2():255-61. PubMed ID: 3106738
    [No Abstract]   [Full Text] [Related]  

  • 12. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
    Titus RG; Lima GC; Engers HD; Louis JA
    J Immunol; 1984 Sep; 133(3):1594-600. PubMed ID: 6205088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity to experimental infection with Leishmania major: generation of protective L3T4+ T cell clones recognizing antigen(s) associated with live parasites.
    Müller I; Louis JA
    Eur J Immunol; 1989 May; 19(5):865-71. PubMed ID: 2500348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation.
    Budd RC; Cerottini JC; Horvath C; Bron C; Pedrazzini T; Howe RC; MacDonald HR
    J Immunol; 1987 May; 138(10):3120-9. PubMed ID: 3106474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.
    Stern JJ; Oca MJ; Rubin BY; Anderson SL; Murray HW
    J Immunol; 1988 Jun; 140(11):3971-7. PubMed ID: 3131421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subpopulations of early thymocytes. A cross-correlation flow cytometric analysis of adult mouse Ly-2-L3T4-(CD8-CD4-) thymocytes using eight different surface markers.
    Wilson A; D'Amico A; Ewing T; Scollay R; Shortman K
    J Immunol; 1988 Mar; 140(5):1461-9. PubMed ID: 2894393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of protective T cells from BALB/cJ mice chronically infected with Leishmania donovani.
    Holaday B; Sadick MD; Pearson RD
    J Immunol; 1988 Sep; 141(6):2132-7. PubMed ID: 3262649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exacerbation of experimental murine cutaneous leishmaniasis with CD4+ Leishmania major-specific T cell lines or clones which secrete interferon-gamma and mediate parasite-specific delayed-type hypersensitivity.
    Titus RG; Müller I; Kimsey P; Cerny A; Behin R; Zinkernagel RM; Louis JA
    Eur J Immunol; 1991 Mar; 21(3):559-67. PubMed ID: 1672641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of early stages of T lymphocyte development in the thymus cortex and medulla.
    Scollay R; Shortman K
    J Immunol; 1985 Jun; 134(6):3632-42. PubMed ID: 3886788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
    Liew FY; Dhaliwal JS
    J Immunol; 1987 Jun; 138(12):4450-6. PubMed ID: 3295049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.